Listar por autor "Carpio Segura, Cecilia Carmen"
Mostrando ítems 1-6 de 6
-
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
Hodkinson, Brendan P.; Schaffer, Michael; Brody, Joshua D.; Jurczak, Wojciech; Carpio Segura, Cecilia Carmen; Ben-Yehuda, Dina (Elsevier, 2021-01) -
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
Bobillo Varela, Sabela; Crespo Maull, Marta; Escudero Monreal, Laura; Mayor Ferreras, Regina Gabriela; Raheja Makhija, Priyanka; Carpio Segura, Cecilia Carmen; Rubio Pérez, Carlota; Tazón Vega, Bárbara; Palacio García, Carlos; Carabia Juberó, Júlia; Jiménez Bernal, Isabel; Nieto Sáchica, Juan Camilo; Montoro Gómez, Mª Julia; Martínez Ricarte, Francisco Ramón; Castellví Vives, Josep; Simo Perdigo, Marc; Puigdefabregas Horta, Lluis; Abrisqueta Costa, Pablo; Bosch Albareda, Francesc; Seoane Suarez, Joan (Ferrata Storti Foundation, 2021-02-20) -
Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study
Rodriguez-Pinilla, Socorro Maria; Domingo Domenech, Eva; Climent, Fina; Sanchez, Joaquin; Perez Seoane, Carlos; López-Jiménez, Javier; Carpio Segura, Cecilia Carmen; Castellví Vives, Josep (Wiley, 2021-01) -
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
Salamero García, Olga; Montesinos, Pau; Willekens, Christophe; Pérez-Simón, José Antonio; Pigneux, Arnaud; Récher, Christian; Carpio Segura, Cecilia Carmen; Bosch Albareda, Francesc (American Society of Clinical Oncology, 2020-12-20) -
The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
Rejeski, Kai; Perez, Ariel; Iacoboni García-Calvo, Gloria Inés; Penack, Olaf; Bücklein, Veit; Jentzsch, Liv; Carpio Segura, Cecilia Carmen; Barba Suñol, Pere (BMJ, 2022-05) -
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
Timmerman, John; Herbaux, Charles; Ribrag, Vincent; Zelenetz, Andrew D.; Houot, Roch; Neelapu, Sattva S.; Carpio Segura, Cecilia Carmen (Wiley, 2020-05)